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Retinal diseaseThe morbidity of ocular diseases, including macular degeneration, diabetic retinopathy, and dry eye disease,
has been gradually increasing worldwide. Because these diseases develop from age-associated ocular dys-
functions, interventions against the aging process itself may be a promising strategy for their management.
Among the several approaches to interrupt aging processes, calorie restriction (CR) has been shown to recov-
er and/or slow age-related functional declines in various organs, including the eye. Here, we review interven-
tions against the aging process as potential therapeutic approaches to age-related ocular diseases. The effects
of CR and CR mimetics in animal models of age-related eye diseases are explored. Furthermore, we discuss
the possibilities of expanding this research to prospective studies to elucidate the molecular mechanisms
by which CR and/or CR mimetics preserve ocular functions.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license.1. Introduction
Aging is thought to play an important role in many eye diseases,
including cataracts, age-relatedmacular degeneration (AMD), glauco-
ma, dry eye disease, pterygium, conjunctival chalasis, diabetic retinopa-
thy, and retinal vein occlusion. These disorders account for more than
80% of all eye diseases, and their incidence has been gradually increasing
worldwide because of aging populations and longer life expectancies.
Preventive measures for aging and early disease intervention are
good strategies because the aging processes are closely related to var-
ious ocular conditions that result from diminished functions. Calorie
restriction (CR) reverses or slows age-related functional declines in
various organs (Bordone and Guarente, 2005; Fontana et al., 2008; Lin
et al., 2004; Wolf, 2006), including the eye (Abe et al., 2001; Heilbronn
et al., 2006; Kawashima et al., 2010; Li and Wolf, 1997; Nadakavukaren
et al., 1987; Obin et al., 2000a, 2000b). Ocular diseases that have been
studied include age-related macular degeneration, cataract, dry eyelogy, Keio University School of
582, Japan. Tel.: +81 3 3353
nc. Open access under CC BY-NC-SA lidisease, and corneal endothelial cell loss. Although it remains controver-
sial whether CR can prevent age-related eye diseases, most data suggest
that CR is a useful intervention to control various ocular diseases. Here,
we review the clinical evidence and animal model ﬁndings suggesting
that CR and CR mimetics have therapeutic beneﬁts in age-related ocular
diseases. Furthermore, we suggest expansion of the research to prospec-
tive studies in order to further understand the molecular mechanisms
inﬂuenced by CR and CRmimetics in the preservation of ocular function.
Particular attention is given to the effects of CR onmitochondria, sirtuins,
and levels of reactive oxygen species (ROS).We also brieﬂy discuss some
antioxidants that can have similar effects as CR mimetics, and their bio-
chemical availability for disease prevention. Together, these discussions
summarize the molecular mechanisms underlying the protection of tis-
sue from age-related changes.
2. Impact of calorie restriction on ocular diseases
2.1. Dry eye disease
Dry eye disease is an important public health problem with a rapidly
increasing prevalence in aging populations. The disorder causes ocular
discomfort, fatigue, and visual disturbances that often interfere with
daily activities. Lacrimal gland function gradually decreases with age,
leading to reduced tear secretion and increased dry eye morbidity in el-
derly people (Lu et al., 2008; Schaumberg et al., 2002; Uchino et al., 2006).cense.
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rimal gland function and morphology in middle-aged rats (Kawashima
et al., 2010). This was thought to result from reductions in oxidative
stress status and inﬂammation. Aging occurs, in part, as a result of in-
creasing levels of oxidative stress fromaccumulation of ROS that are con-
tinuously generated during normal metabolic processes. Mitochondria
produce high amounts of ROS and are the main source of cellular
organelle ROS. Kawashima et al. (2010) showed that compared with
lacrimal glands of rats fed ad libitum, lacrimal glands of CR rats produced
a higher volume of tears and had more intact mitochondrial structures.
Because the lacrimal glands from CR rats also had lower amounts of
8-hydroxydeoxyguanosine (8-OHdG), an oxidized nucleoside of DNA,
and 4-hydroxynonenal (HNE), the authors concluded that lacrimal
gland preservation could be attributed to lower oxidative stress.
Recently, our research group also obtained data that indicated a
direct inﬂuence of mitochondrial ROS on lacrimal gland function in sev-
eral different rodent models of oxidative stress, including Tet-mev-1
mice, superoxide dismutase 1 (SOD1) knockout mice, and smoking
rats. Additionally, we demonstrated that corneal epithelial cell dam-
age is mediated by oxidative stress (Nakamura et al., 2007, 2010;
Higuchi et al., 2011; Kojima et al., 2012) and that oxidation of ocular
surface protein, fat, and DNA is accelerated (Nakamura et al., 2007,
2010) in a blink-suppressed rat model of severe dry eye. Blink sup-
pression itself can over-expose the ocular surface to ambient oxygen
and induce direct oxidation of cellular components. Kojima et al. (2012)
reported that mice with genetically disrupted SOD1, a key enzyme in-
volved in superoxide anions (O2−) control, exhibited lacrimal gland dys-
function and a compromised ocular surface. Additionally, Uchino et al.
(2012) found that the excessive mitochondrial electron transport
chain ROS production in Tet-mev-1mice induced lacrimal inﬂammation
and corneal injury. Together, these studies suggest that mitochondrial
oxidative stress, combinedwith the dysfunction of the electron transport
chain, can inﬂuence the pathogenesis and progression of age-related
lacrimal gland and corneal deﬁciencies, accelerating the aging of these
tissues.
Higuchi et al. (2011) observed that elevated ROS levels, induced by
smoking, reduced lacrimal gland function through an upregulation of poly-
peptide cytochrome P450, family 1, subfamily A1 (CYP1A1) in the lacrimal
gland ducts. The elevated CYP1A1 levels led to further increases in lacrimalTable 1
Previous publications regarding calorie restriction (CR) on age-related eye diseases in anim
Eye diseases Calorie restriction effect
Dry eye Positive Tear secretion
Cataract Positive Delayed onset, formation, progression of cataract
Positive Decline of proliferative capacity of lens epithelial cells
(in vitro and in vivo)
Positive Attenuated age-related shortening of telomeres in lens
epithelial cells/retarded age-related degeneration of lens
by reducing oxidative stress in the lens/prevented age-re
decline in glycolytic enzymes, molecular chaperones
Positive Delayed onset, formation, and progression of cataracts
Positive Improved alpha-crystallin chaperone activity.
Lowered β- and γ-crystallin aggregation
Negative
Retinal diseases Positive Decreased the accumulation of lipofuscin in retinal pigm
epithelial cells
Negative Deleterious effect of bright light was more pronounced in C
Positive Neuroprotective effects
Reduced age-related photoreceptor cell death
Reduced decline of thiols, glutathione, ascorbic acid, and
taurine in the retina
Positive Protected against the loss of retinal ganglion cells (RGCs)
Positive Attenuated loss of age-related RGCsROS production. The exact molecular mechanism bywhich elevated levels
of ROS affect the lacrimal gland and tear production are still unclear, and
further experiments are required to clarify these mechanisms. However,
these observations still shed light on the prevention of age-related decline
in lacrimal gland function.
2.2. Cataracts
Senile cataracts of the eye lens are a major cause of blindness, partic-
ularly among the elderly. As summarized in Table 1, most animal studies
indicate a positive effect of CR on cataracts. Senile cataract models, such
as those in the Emory mouse and brown Norway rat, indicate that CR
delays the onset, formation, and progression of cataracts (Taylor et al.,
1989; Gong et al., 1997). CR may retard age-related degeneration of
the lens by slowing aggregate formation, including those of gamma-
and alpha-crystallins, which is associated with attenuation of oxidative
stress in the lens (Mura et al., 1993; Wang et al., 2004). These studies
clearly suggest that CR diets provide protection against cataract forma-
tion in pigmented animals, but not in albinos. This anomaly in albino
rodents may be related to their greater susceptibility to light-induced
damage than that in normal, pigmented rodents.
2.3. Retinal diseases
AMD causes central vision loss and is the leading cause of blindness in
developed countries. By 2020, over 7.5 million people aged>65 years are
estimated to have vision loss resulting from AMD (Taylor and Keeffe,
2001). Because of these alarming statistics, research has focused on
ways to delay disease progression and the resulting retinal damage.
Lipofuscin, resulting from phagocytosis of degraded photoreceptor
cells, is an aggregate of complex materials that accumulates in the
lysosomes of retinal pigment epithelial (RPE) cells. Age-related accu-
mulation of lipofuscin may result in RPE dysfunction and accelerate
aging processes within the retina, resulting in AMD (Sparrow et al.,
2006). In Wistar rats, CR decreases lipofuscin accumulation in RPE cells
(Katz et al., 1993). Additionally, in brown Norway rats, CR exhibits
neuroprotective effects in aged retinas by reducing age-related photore-
ceptor cell death (Obin et al., 2000a, 2000b). This process was attenuated
by reducing oxidative stress and/or by sustaining the pool of protectiveal models.
Animal References
Fischer 344 rats Kawashima et al. (2010)
Emory mice Taylor et al. (1989), Mura et al. (1993)
and Taylor et al. (1995a, 1995b)
C57BL/6 × DBA/2 mice Li et al. (1997)
lated
Brown Norway rats Wolf et al. (2000), Pendergrass et al.
(2001) and Wang et al. (2004)
(C57BL/6, (C57BL/6 × DBA/2)F1,
(C57BL/6 × C3H)F1) mice
Wolf et al. (2000)
Wistar rats Reddy et al. (2002)
Fischer 344 rats Wolf et al. (2000)
ent Wistar rats Katz et al. (1993)
R rats Albino Fischer 344 rats Obin et al. (2000a, 2000b)
Brown Norway rats Obin et al. (2000a, 2000b), Li et al.
(2003) and Li et al. (2004)
Albino Fischer rats, Kawai et al. (2001)
Albino Wistar rats,
Brown Norway rat
Albino BALB/cBy mice Neufeld and Gachie (2003)
Albino Fischer rats
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2003). However, in Fischer 344 rats, CR increased light-dependent photo-
receptor cell loss in the neural retina (Obin et al., 2000a, 2000b).
Retinal ganglion cells, which are neurons that transmit visual
information from the retina to the brain, decrease in number with
advancing age (Neufeld and Gachie, 2003); CR slows the age-related
loss of these cells (Neufeld and Gachie, 2003). These studies suggest
that CR protects against the loss of these cells, irrespective of the pig-
mentation of the animal.
3. Calorie restriction mimetics
Although CR may have beneﬁcial effects in humans, it is very dif-
ﬁcult to implement and maintain. Therefore, vigorous efforts have
been made to ﬁnd alternative ways to induce the beneﬁts of CR, with-
out imposing the strict guidelines required by CR. With the knowl-
edge of the molecular mechanisms involved in the beneﬁts of CR,
suitable chemical compounds or natural products may be found to
mimic the effects of CR. Candidate compounds include several poly-
phenols, lactoferrin, astaxanthin, lipoic acid (α-lipoic acid or ALA), and
deoxy-D-glucose (or 2-DG), in addition to currently used drugs such as
metformin, rimonabant, and rapamycin. In particular, metformin is
already clinically approved to treat diabetes, and has been used for this
indication for the past 40 years. It is considered to be a receptor sensitiz-
er, because it enhances the sensitivity of insulin receptors on the surface
of muscle and fat cells. Metformin activates genes that reduce the pro-
duction of glucose and reduces the gene expression for enzymes that
increase oxidation of fatty acids, which correspond to the same actions
of CR genetic effects.
Studies strongly suggest that in a manner similar to CR, these com-
pounds modulate numerous inﬂammatory pathways throughout the
human body, including in the eyes. Several CR mimetics have been
tested on various age-related eye diseases, and several compounds have
shown promise in delaying the onset of age-related eye diseases. Poly-
phenols (including resveratrol, quercetin, anthocyanin, and curcumin)
and other candidate CR mimetics (such as lactoferrin, lutein, and
eicosapentaenoic acid) have been the most frequently studied in
eye diseases. Therefore, this review focuses on these possible phyto-
chemical CR mimetics, including how they may be beneﬁcial in
managing or preventing age-related eye diseases.
3.1. Polyphenols
A small molecule that safely mimics the ability of CR to delay
age-related diseases in laboratory animals is highly sought after. Res-
veratrol is a type of polyphenol found in the skin of red grapes and
other fruit. It is a popular CR mimetic and has been shown to suppress
age-related pathological conditions (Timmers et al., 2011). Recent an-
imal studies have shown that independent of change in body weight,
a steady and sufﬁcient resveratrol intake reverses the lower survival
rate that is induced by a high-fat, high-calorie diet. This effect involves
an increase in insulin sensitivity and in mitochondrial numbers, both
of which are negatively affected by excessive oxidative stress.
Autophagy is also associated with both CR and resveratrol intake.
The involvement of the pathway through which sirtuin 1 (SIRT1)
and/or its upstream AMP-activated protein kinase (AMPK) acts is a
well-known mechanism underlying CR beneﬁts. A recent study dem-
onstrated that daily resveratrol intake in obese humans improved
their general condition and beneﬁcially increased SIRT1 gene expres-
sion (Timmers et al., 2011). However, another recent study reported
that resveratrol supplementation does not improve metabolic func-
tion in non-obese women with normal glucose tolerance (Yoshino
et al., 2012).
In the eye, resveratrol suppresses vascular lesions associated with
diabetic retinopathy (Kubota et al., 2011) and decreases the innate
retinal inﬂammation in endotoxin-induced uveitis (Kubota et al., 2009).In diabetic retinopathy, AMPK activation is the known mechanism for
vascular lesion suppression, and the effects of resveratrol have been
reproduced with the AMPK activator 5-aminoimidazole-4-carboxamide
ribonucleoside (AICAR) (Kubota et al., 2011). Resveratrol also has a
neuroprotective effect in light-induced retinopathy (Kubota et al., 2010).
Pearson et al. (2008) found that resveratrol induces gene expres-
sion patterns in multiple tissues; these patterns parallel those induced
by CR and every-other-day feeding in mice. Moreover, resveratrol-fed
elderly mice showed amarked reduction in signs of aging, including re-
duced cataract formation (Pearson et al., 2008). Doganay et al. (2006)
reported that resveratrol suppressed selenite-induced oxidative stress
and cataract formation in rats; these ﬁndings were supported by higher
Glutathione and lower malondialdehyde in lenses and erythrocytes.
The presence of oxidative stress in development of selenite cataract
and its prevention by resveratrol suggest that consumption of foods
with high levels of natural resveratrol may help prevent the formation
of senile cataracts in humans (Doganay et al., 2006).
Among other polyphenols, a ﬂavonoid phytopigment (anthocyanin)
may have health beneﬁts, including obesity control, diabetes control, pre-
vention of cardiovascular disease, and improvement of visual functions
(Tsuda, 2012). Anthocyanins can suppress retinal neurodegeneration
caused by innate retinal inﬂammation (Miyake et al., 2012). Another
polyphenol, quercetin, has shown effectiveness against cataract forma-
tion (Stefek and Karasu, 2011).
3.2. Other CRM compounds with proven beneﬁcial effects on eye diseases
3.2.1. Lutein
Lutein, a carotenoid belonging to the xanthophylls group, is con-
centrated in the macula (center of the retina) and is referred to as a
macular pigment in humans. Based on the results of small-scale clinical
studies, lutein is thought to prevent AMDdevelopment and progression
and is now being studied as part of a very large, prospective trial, the
Age-Related Eye Disease Study 2 (AREDS2).
The biological effects of lutein have been elucidated through several
animal studies (Ozawa et al., 2011, 2012). The carotenoid can suppress
retinal neuronal degeneration in diabetic retinopathy (Sasaki et
al., 2010), innate retinal inﬂammation in endotoxin-induced uveitis
(Sasaki et al., 2009), and neurodegeneration in light-induced reti-
nopathy (Sasaki et al., 2011). This protective effect against excessive
light exposure is consistent with the belief that lutein is physiologically
present to absorb excess light and to prevent or minimize light-induced
retinal damage. In the 3 reports described above, the induced pathologi-
cal oxidative stress was successfully suppressed by lutein administration.
3.2.2. Eicosapentaenoic acid
Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty
acid (PUFA), abundantly present in ﬁsh, and is also being studied in
AREDS2. Daily dietary supplementation with EPA suppressed the de-
velopment of laser-induced choroidal neovascularization in a mouse
model of AMD (Koto et al., 2007). Interestingly, EPA dietary supplemen-
tation also affects the systemic ratio of omega-3 to omega-6 PUFAs;
omega-3 PUFA levels increase not only in blood cells but throughout
the body. EPA also suppresses innate retinal inﬂammation in mice
with endotoxin-induced uveitis (Suzuki et al., 2010). Additionally,
EPA/docosahexaenoic acid consumption is negatively related to the
incidence of dry eye (Schaumberg et al., 2003; Miljanovic et al., 2005),
and EPA administration may be helpful in treating the condition.
3.2.3. Lactoferrin
Lactoferrin is an antioxidant and an important component in tears.
Animal and human data have demonstrated that oral lactoferrin in-
take may increase tear volume and ameliorate the symptoms of dry
eye (Dogru et al., 2007; Kawashima et al., 2012). Although lactoferrin
alleviates symptoms of dry eye disease in both animals and humans,
1099M. Kawashima et al. / Experimental Gerontology 48 (2013) 1096–1100the mechanisms of its absorption in the body after oral intake and its
stabilization of tear ﬁlm are still unknown.
4. Future directions
Animal model studies have shown that CR slows age-related de-
clines in ocular functions by attenuating oxidative stress. These types
of CR interventions may be effective in humans as well, although the
practicality of such an approach in humans makes clinical studies difﬁ-
cult; this approach has not been broadly studied in the clinical setting.
Now that CR mimetics are known to control ROS in a similar way as
CR, clinical studies with dietary supplements can be performed.
Improvement of mitochondrial function with CR mimetics may have a
great potential for managing, slowing, or even preventing age-related
disorders.
Although we have not commented on the beneﬁts of exercise in
this review (Mares et al., 2011; Yip et al., 2011), we believe that proper
exercise regimens and adequate CR and/or CR mimetic therapy may be
synergistic and important interventions against various age-related eye
disorders. Investigations into the effects of CR on eye disease will contin-
ue, with the goal of elucidating themolecularmechanisms underlying its
beneﬁcial effects on age-related and inﬂammatory ocular disorders. CR
mechanism-based compounds, including sirtuin activators and AMPK
upregulators, are expected to be developed to enable the broad applica-
tion of the beneﬁts of CR in the clinical setting.
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